ABSI Stock Risk & Deep Value Analysis
Absci Corp
Healthcare • Biotechnology
DVR Score
out of 10
The Bottom Line on ABSI
We analyzed Absci Corp using our deep value framework. Sign in to see our full verdict and DVR Score.
We ran ABSI through our deep value framework — analyzing financial health, distress signals, competitive moat, and risk factors. Here's what we found.
Get notified when ABSI moves
Same alert types as Telegram — presets or custom thresholds in your 🔔 feed.
📈ABSI Performance Overview3yr weekly
Unlock ABSI Performance Chart
See 3 years of price history, quarterly revenue trends, and DVR score changes
Weekly adjusted close · Quarterly revenue & EPS · DVR score history
ABSI Quality Rating
ABSI Stock Risk Analysis
Overall Risk
Aggressive
Financial Risk
High
Market Risk
Medium
About Absci Corp (ABSI)
Sector
Healthcare
Industry
Biotechnology
Market Cap Category
small
Market Cap
$468.00M
ABSI Deep Value Analysis
ABSI Research Sources
No external source links for this analysis yet. Run a fresh analysis to capture SEC filings and financial news articles we used.
For educational context only. Not financial advice.
ABSI Red Flags & Warning Signs
- ⚠
Failure to secure new partnerships or revenue streams in 2026
- ⚠
Further acceleration of cash burn beyond $94M TTM
- ⚠
Highly dilutive capital raise due to dwindling cash runway
Unlock ABSI Red Flags & Risk Warnings
Premium members see every risk event we found.
Unlock the full report
Create a free account to see the DVR score, risk flags, and AI analysis.
Unlock everything for $47/yr
$79/yrSave 41%
- ✓ Catalysts, bull case, moat & red flags
- ✓ Unlimited stock analyses + alerts
- ✓ Full database, search & portfolio (50 stocks)
7-day money back · Cancel anytime
ABSI Financial Health Metrics
Market Cap
$468.00M
P/E Ratio
0.00
Profit Margin
0.00%
Debt-to-Equity
0.00
Dividend Yield
0.00%
Beta (Volatility)
0.00
Earnings Per Share
$-0.23
ABSI Competitive Moat Analysis
Moat Rating
Narrow
Moat Trend
Stable to Eroding. While the technology is strong, the recent clinical setback and revenue decline raise questions about the platform's immediate efficacy and ability to generate superior drug candidates compared to rivals, potentially making future partnerships harder to secure.
Moat Sources
2 Identified
The moat's durability relies heavily on Absci's ability to demonstrate consistent success in drug discovery through its platform, securing long-term, high-value partnerships, and continually advancing its proprietary AI and data. Failure to do so could lead to competitors closing the technological gap.
ABSI Competitive Moat Analysis
Premium unlocks moat rating, sources & durability.
ABSI Catalysts & Growth Drivers
Near-Term (0-6 months)
- •Q1 2026 Earnings (No specific date, likely May 2026)
- •Announcement of new, significant drug discovery partnerships
Medium-Term (6-18 months)
- •Progression of existing collaboration programs to advanced milestones
- •Positive preclinical or Phase 1 data from new internal programs (not ABS-101)
Long-Term (18+ months)
- •Broad adoption of Absci's AI platform across the pharmaceutical industry
- •Successful commercialization of a drug discovered using Absci's platform
Catalysts & Growth Drivers
Sign up free to see growth catalysts
ABSI Bull Case: What Could Go Right
- ✓
Announcement of multiple new, significant collaboration agreements (>$5M upfront payment each)
- ✓
Clear progress on alternative internal drug programs beyond ABS-101, with positive preclinical or early clinical data.
- ✓
Reduction in the quarterly cash burn rate or positive free cash flow guidance.
Bull Case Analysis
Sign up free to see the bull case
📊 Explore More Stock Analysis
Get comprehensive Deep Value Reports for thousands of stocks. Research risk, financial health, and investment potential.
FAQ
What is the DVR Score for Absci Corp (ABSI)?
As of April 11, 2026, Absci Corp has a DVR Score of 4.3 out of 10, placing it in the "Proceed with Caution" category. This score is generated by our AI-powered deep value analysis framework that evaluates growth potential, financial health, competitive moat, and risk factors.
What is the market capitalization of Absci Corp?
Absci Corp's market capitalization is approximately $468.0M. The company operates in the Healthcare sector within the Biotechnology industry.
What ticker symbol does Absci Corp use?
ABSI is the ticker symbol for Absci Corp. The company trades on the NMS.
What is the risk level for ABSI stock?
Our analysis rates Absci Corp's overall risk as Aggressive. This assessment considers execution risk, market risk, financial risk, competitive risk, and regulatory risk. For a full breakdown, see the risk analysis section above.
Is Absci Corp's revenue growing?
Absci Corp has reported revenue growth of -37.8%. Revenue has been declining, which warrants closer examination.
Is ABSI stock profitable?
Absci Corp has a profit margin of 0.0%. The company is currently unprofitable.
How often is the ABSI DVR analysis updated?
Our AI-powered analysis of Absci Corp is refreshed regularly to incorporate the latest financial data, market conditions, and news. The most recent update was on April 11, 2026.
Important Disclaimer – Not Financial Advice
Deep Value Reports is an independent research platform for educational and informational purposes only. We are not financial advisors, investment advisors, or licensed professionals. The analysis, scores, and information provided should not be construed as personalized investment advice, a recommendation to buy or sell any security, or an offer to provide investment advisory services.
All investments involve risk, including the potential loss of principal. Past performance does not guarantee future results. Always conduct your own research and consult with a qualified financial advisor.